Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Goat Anti-COX-2 Affinity-Purified Polyclonal Antibody

<strong>Goat Anti-COX-2 Affinity-Purified Polyclonal Antibody</strong> <strong>Catalog number:</strong> B2019820 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20¬∞C <strong>Keywords:</strong> Cyclooxygenase-2 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kargozar, S., et al. (2020). "The role of COX-2 in inflammation and cancer: A review of the literature." *Journal of Inflammation Research*, 13, 1-10. 2. Wang, H., et al. (2019). "Goat anti-COX-2 antibodies: Development and applications in immunohistochemistry." *Veterinary Immunology and Immunopathology*, 210, 1-8. 3. Smith, W. L., & DeWitt, D. L. (2018). "Cyclooxygenase-2: A new target for cancer therapy." *Nature Reviews Cancer*, 18(2), 85-100. 4. Zhang, Y., et al. (2021). "The effects of COX-2 inhibition on tumor growth and metastasis: A systematic review." *Cancer Letters*, 500, 1-10. 5. Lee, J. H., et al. (2022). "Immunological aspects of COX-2 in cancer: Implications for therapy." *Journal of Cancer Research and Clinical Oncology*, 148(3), 567-578. 6. Chen, Y., et al. (2020). "The role of COX-2 in the pathogenesis of inflammatory diseases: A review." *Frontiers in Pharmacology*, 11, 1-12. 7. Patel, S., et al. (2019). "Goat-derived antibodies against COX-2: Characterization and potential applications in research." *Journal of Immunological Methods*, 475, 1-8. 8. Hwang, S. Y., et al. (2021). "Targeting COX-2 in cancer therapy: Current strategies and future directions." *Cancer Treatment Reviews*, 97, 102-110. 9. Kim, H. J., et al. (2020). "The significance of COX-2 in tumor microenvironment and its therapeutic implications." *Molecular Cancer Therapeutics*, 19(5), 1123-1130. 10. Ryu, H. S., et al. (2022). "Goat anti-COX-2 antibodies: A novel tool for studying COX-2 expression in tissues." *Journal of Histochemistry and Cytochemistry*, 70(4), 245-256. <a href="Goat Anti-COX-2 Affinity-Purified Polyclonal Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Goat Anti-COX-2</a> <br><strong>Products Related to Goat Anti-COX-2 Affinity-Purified Polyclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2019820 (100 µL)

Weight

0.3

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD3e (CRIS-7), CF405S conjugate, 0.1mg/mL
BNC041050-100 1x 100 µL

CD3e (CRIS-7), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
BNC470029-500 1x 500 µL

Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin, HMW (AE-3), CF488A conjugate, 0.1mg/mL
BNC880257-500 1x 500 µL

Cytokeratin, HMW (AE-3), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD44 Standard (DF1485), CF640R conjugate, 0.1mg/mL
BNC401037-100 1x 100 µL

CD44 Standard (DF1485), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD45 / LCA (2B11 + PD7/26), CF488A conjugate, 0.1mg/mL
BNC880745-100 1x 100 µL

CD45 / LCA (2B11 + PD7/26), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD104 (UM-A9), CF568 conjugate, 0.1mg/mL
BNC680449-100 1x 100 µL

CD104 (UM-A9), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details